The 1 st National TB Prevalence Survey Nigeria 2012

Size: px
Start display at page:

Download "The 1 st National TB Prevalence Survey Nigeria 2012"

Transcription

1 The 1 st National TB Prevalence Survey Nigeria 2012 Preliminary/Final Results 29 th April 2013 Dr. Joshua Obasanya NTP Manager/ PI National TB Prevalence Survey

2 Background Indicator (2011) Population size 162.5million GNI per capita (Atlas method) 2011($1,280) Estimated TB Burden (2011) Number Rate Cases (all forms) 190, /100,000 (2011) Mortality 17 per 100,000 (2011) TB cases with HIV 30% (2011) N/A Case notifications 60 per 100,000 Treatment success 85.5% 2

3 Methodology

4 Sampling design Sample size: 49,000 eligible adults (15 yrs and above) Number of clusters: 70 A multi-stage sampling method was used Stratifying the country into 6 geopolitical zone Population based simple random sampling <70> clusters <700> people 4 <49,000> Target

5 Selection criteria and health seeking behaviour Inclusion criteria All permanent residents in the household Non-permanent residents who have spent at least 2 weeks in the household by the survey day At least 15 years of age Those who have provided informed consent Screening Positive Two sputum samples (1 spot and 1 morning) will be obtained from persons reporting a cough greater than or equal to 2 weeks in duration or chest X- ray examination that show any radiographic abnormalities. Health seeking behaviour (2 questions) What did you do about your symptoms? (Not recognised as illness, ignored, self treatment, consulted health service, others <specify>) If response to question above is consulted health service, Where did you first seek care? (HC/PHC, Private Hosp., Traditional healer, Chemist, GH, Teaching Hosp., Mission Hosp., others <specify>) 5

6 Laboratory methods Smear: Direct in 2 Labs and Concentrated in 1 Lab Ziehl-Neelsen staining Culture media: Löwenstein Jensen (LJ) For positive growths, identification for MTBC was done Other: 3 Refence Labs were used ( Zankli, NTBLTC Zaria and NIMR) Use of GeneXpert MTB/RIF for few samples with inconsistent results ( specifically for Zaria processed samples) e.g. 1 smear pos sample, cultve, X-ray TB suggestive 6

7 Main Challenges

8 Main challenges of survey implementation S/No Challenge Action 1 On-going security challenges in Kano, Kaduna, Yobe and Borno states 2 states (Yobe & Borno) were excluded. To compensate, 3 clusters with similar characteristics were chosen for replacement 2 Low participation due to Rain/Farming/Fasting period 3 Absenteeism experienced in urban settings 4 Backlog and increased workload for Zaria Laboratory ( because 2 clusters ran concurrently) 5 Gaps between field sample collection and lab reporting and between lab reporting and feedback to participants for enrolment of care. These was coupled with sputum transport challenges 6 Delay in Central Xray reading and entry into data base 7 Delayed Procurement (especially lab equipments & consumables availability and specification) which resulted in late take-off of the survey suspension of survey field activities for 5 weeks (from end of July August 26 th 2012) Field teams worked till late hours while re-mobilization was done through community & religious leaders Zankli Lab was engaged to support in processing some of samples already delivered to Zaria Labs were visited routinely every 2 weeks to retrieve results that were delayed Survey central team developed and regularly updated the list of detected cases on weekly basis. Feedbacks of results were sent to patients through State Program officers and Zonal survey coordinators Feedback on enrolment of detected cases received during review meetings Change from public transport to courier transport 5 Additional data clerks were identified to support the central data manager with entry of central X-ray and Lab results. The NTP had to intervene Case review style exercises were consistently carried out with support from WHO 8 Geneva & CDC Atlanta to improve the quality of data generated

9 RESULTS

10 Participants Total census 113,057 Eligible to participate 77,596 (68.6%) 34,962 (31%) children 499 (0.44%) non-residents Ineligible individuals Participants 43,439 (56%) 10

11 Eligibility by age group and sex Eligibility by age group and gender Percentage eligible (%) 95.0 Male Female to to to to to Age group (years)

12 Participation by age group and sex Overall participation rate: 56% Participation by age group and sex 90.0 Participation rate(%) Male Female to to to to to Age Group (Years) 12

13 Participation by cluster 100 Participation rate by cluster (chronological order) Participation rate (%) Cluster number 13

14 Screening and laboratory investigations Total screened Symptom positive CXR positive Both symptom and CXR positive Screened positive Total specimens obtained Number of participants with lab results 43,439 4,429 (10%) 2,016 (45.5%) 724 (16.4%) 1,670 (38.1%) 4,283 (at least one specimen) 4,283 14

15 Results of TB Prevalence : Age 15years* 1) Smear Positive MTB case (N=107): 255 per 100,000 (95%CI ) Correlation coefficient of between-cluster variation (k): 0.82 Design effect: ) Bacteriologically Confirmed MTB (N=148): 353 per 100,000 (95%CI ) Correlation coefficient of between-cluster variation (k): 0.78 Design effect:

16 Prevalence of culture confirmed MTB cases by age: 1400 Prevalence of smear-positive and bacteriologically-confirmed TB by age group 1200 Prevalence per 100, Smear positive culture positive Bacteriologically positive Age group (years) 16

17 Prevalence of culture confirmed smear positive TB by age and sex: 3000 Prevalence of bacteriologically-confirmed TB by sex and age group 2500 Prevalence (per 100,000) Male Female Age group (Years) 17 Age Group (Years)

18 Confirmed MTB survey cases: Symptoms and CXR screening results <Complete this table> Screening method Smear positive MTB survey cases N=107 Bacteriologically confirmed MTB survey cases N=148 Total number of survey cases Percentage of all survey cases Total number of survey cases Percentage of all survey cases Symptom positive only 13 12% % CXR positive only 27 25% % Symptom and CXR positive 67 63% 77 52% What proportion of MTB survey cases were smear negative? 27.7% What proportion of MTB survey cases were detected by CXR? 36.5% What proportion of MTB survey cases were detected by symptoms? 11.5% What proportion of MTB survey cases would have been detected by the current screening strategy in your country? 11.5% 18

19 Comparison of Prevalence to Notification (2011) 8 Prevalence to Notification Rate ratios; total, by sex, and age group Comparison of notification (2011) to prevalence (smear-positive) 7 Prevalence to Notification ratio National (15+) Male (15+) Female (15+) 15 to 24 yrs Categories 25 to 34 yrs 35 to 44 yrs 45 to to yrs yrs yrs 19

20 Lessons Learnt

21 Major lessons and implications to the NTP What are the main lessons derived from the survey results? 21 Data management is the bedrock of a successful survey (a simplified and user friendly database is crucial). Low participation rate (56%) 75% of smear positive study cases are symptomatic (consistent with 2013 Prog. Rev. findings) Participation rate higher in females and older individuals ( health seeking behaviour among men still a challenge) Survey findings (prevalence) seems to be higher than current WHO estimates (further analysis required) What action is recommended based on the findings? Modern and strategic approaches to creating awareness within the community is pertinent Strategic expansion of more microscopy centers than DOTS centers to increase access to diagnosis is needed Stakeholders meeting to brainstorm on strategies for increasing case detection

22 Acknowledgements 22

23 23 Dedication, mutual responsibility and a sound data management system!

24 Supplementary slides

25 Laboratory results Total specimens obtained Any smear positive Any culture MTB S+C+ S-C+ X,XXX (spot) X,XXX (morning) XXX (X.X%) XXX (X.X%) 75(51%) 41 (28%) 25

26 Study cases Smear positive MTB cases Bacteriologically confirmed MTB cases Total number of study cases Definite case Probable case 32 2 Possible case 30 Non-study cases 38 - Number of cases that are smear positive Definite cases: Probable cases: Possible cases: Non-study cases: <Sm pos case, Culture MTB or Xpert Positive> <Sm pos case, No proof of culture or Xpert but CXR consistent with TB> <Sm Pos, Culture not MTB positive ( NA, Neg, Contamination) and CXR not consistent with TB disease> <Possible case including Culture NTM-MOTT> 26

27 Health seeking behaviour Analysis on-going Indicator Total number of TB survey cases Number of TB survey cases who were not on treatment at the time of the interview Number of TB survey cases who were symptomatic Number of symptomatic TB survey cases not on treatment at the time of the interview Number of TB cases detected by the survey who were already on treatment (Where did they seek care?) Number of symptomatic TB cases not on treatment but who sought care (Where did they seek care?) Number of TB survey cases that started on treatment after being detected by the survey 27

The first National TB Prevalence Survey Rwanda 2012

The first National TB Prevalence Survey Rwanda 2012 The first National TB Prevalence Survey Rwanda 2012 Preliminary Results 29 th April 2013 Patrick Migambi Rwanda Biomedical Centre (RBC) Background Indicator (2011) Population size(census 2012) 10,537,222

More information

The National TB Prevalence Survey Pakistan

The National TB Prevalence Survey Pakistan The National TB Prevalence Survey Pakistan 2010-11 Preliminary Results 29 th April 2013 Dr Ejaz Qadeer NTP Manager Principal Investigator Background Indicator (2012) Population size GNI per capita (Atlas

More information

Protocol of National TB Prevalence Survey in Cambodia

Protocol of National TB Prevalence Survey in Cambodia Training workshop for consultants of TB prevalence surveys Protocol of National TB Prevalence Survey in Cambodia 26 February 2011 Phnom Penh, Cambodia Norio Yamada, RIT/JATA Training workshop for consultants

More information

SURVEY FINDINGS April 28, 2017

SURVEY FINDINGS April 28, 2017 SURVEY FINDINGS April 28, 2017 Brenda Mungai Centre for Health Solutions-Kenya, TB ARC Outline Background Survey Rationale Methods Key Findings Conclusions Call to Action KENYA TUBERCULOSIS PREVALENCE

More information

NATIONAL TUBERCULOSIS PREVALENCE SURVEY 2016

NATIONAL TUBERCULOSIS PREVALENCE SURVEY 2016 NATIONAL TUBERCULOSIS PREVALENCE SURVEY 2016 Department of Health/National TB Control Program Philippine Council for Health Research and Development Foundation for the Advancement of Clinical Epidemiology,

More information

Background paper number 7

Background paper number 7 Background paper number 7 Lessons learnt and policy implications from recently completed TB disease prevalence surveys and their interpretation - Vietnam Binh Hoa Nguyen Prevalence survey in Vietnam 2006-2007

More information

National TB Prevalence survey in Myanmar. By Dr. Thandar Lwin Programme Manager National TB Programme Department of Health

National TB Prevalence survey in Myanmar. By Dr. Thandar Lwin Programme Manager National TB Programme Department of Health National TB Prevalence survey in Myanmar By Dr. Thandar Lwin Programme Manager National TB Programme Department of Health 58 million pop. 676,577 sq km (75/sq km) S+ notification rate/100,000 population

More information

Outline. Milestone of survey in Myanmar Objectives Method Results Discussion Limitation Programme implications

Outline. Milestone of survey in Myanmar Objectives Method Results Discussion Limitation Programme implications MHAA Outline Milestone of survey in Myanmar Objectives Method Results Discussion Limitation Programme implications 1972 National TT survey 1994 National Sputum smear positive TB prevalence survey Protocol

More information

Democratic People s Republic of Korea

Democratic People s Republic of Korea National TB prevalence survey Democratic People s Republic of Korea Technical Brief TB National Prevalence Survey Democratic People s Republic of Korea Contents Acknowledgement...iv Acronyms...v Executive

More information

TB Disease Prevalence Survey - Overview and Introduction of the TF

TB Disease Prevalence Survey - Overview and Introduction of the TF TB Disease Prevalence Survey - Overview and Introduction of the TF Ikushi Onozaki MD, MPH Team Leader, TB Prevalence Survey WHO Global Task Force on TB Impact Measurement Stop TB Department, WHO onozakii@who.int

More information

TB Disease Prevalence Survey - Progress Report

TB Disease Prevalence Survey - Progress Report TB Disease Prevalence Survey - Progress Report 30 Oct 2011, Lille Ikushi Onozaki MD, MPH Team Leader, TB Prevalence Survey WHO Global Task Force on TB Impact Measurement Stop TB Department, WHO onozakii@who.int

More information

Xpert MTB/RIF use for TB diagnosis in TB suspects with no significant risk of drug resistance or HIV infection. Results of Group Work

Xpert MTB/RIF use for TB diagnosis in TB suspects with no significant risk of drug resistance or HIV infection. Results of Group Work Xpert MTB/RIF use for TB diagnosis in TB suspects with no significant risk of drug resistance or HIV infection Results of Group Work DOTS expansion and enhancement Objective This group deals with the majority

More information

Report Second National Tuberculosis Prevalence Survey

Report Second National Tuberculosis Prevalence Survey Ministry of Health National Center for Tuberculosis and Leprosy Control Kingdom of Cambodia Nation Religion King Report Second National Tuberculosis Prevalence Survey December 2012 National Tuberculosis

More information

Prevalence Survey -Global Overview- Background, Survey results since 2007, Lessons and Implications to the program Ikushi Onozaki MD MPH WHO HQ STB

Prevalence Survey -Global Overview- Background, Survey results since 2007, Lessons and Implications to the program Ikushi Onozaki MD MPH WHO HQ STB Prevalence Survey -Global Overview- Background, Survey results since 2007, Lessons and Implications to the program Ikushi Onozaki MD MPH WHO HQ STB TME The Global Task Force on TB Impact Measurement WHO

More information

Dr Richard Christopher,(Pediatrician) Ministry of Health and Social Welfare NTLP- TANZANIA Tanzania. Childhood TB Roadmap Paris 0ctober 29

Dr Richard Christopher,(Pediatrician) Ministry of Health and Social Welfare NTLP- TANZANIA Tanzania. Childhood TB Roadmap Paris 0ctober 29 Dr Richard Christopher,(Pediatrician) Ministry of Health and Social Welfare NTLP- TANZANIA Tanzania Childhood TB Roadmap Paris 0ctober 29 Status of childhood TB in Tanzania Child TB linkages with National

More information

CULTURE OR PCR WHAT IS

CULTURE OR PCR WHAT IS CULTURE OR PCR WHAT IS BEST FOR AFRICA? Peter R Mason BRTI TB IN AFRICA GLOBAL 9 MILLION NEW CASES/YR 1.5 MILLION TB DEATHS AFRICA 95% TB DEATHS IN LMIC 9/22 HIGH BURDEN COUNTRIES IN AFRICA STRONG LINK

More information

TB Disease Prevalence Survey - Overview, why and how

TB Disease Prevalence Survey - Overview, why and how TB Disease Prevalence Survey - Overview, why and how Ikushi Onozaki MD, MPH Team Leader, TB Prevalence Survey WHO Global Task Force on TB Impact Measurement Stop TB Department, WHO onozakii@who.int 3 strategic

More information

Xpert MTB/RIF assay validation experience --- impact and plan in China

Xpert MTB/RIF assay validation experience --- impact and plan in China Xpert MTB/RIF assay validation experience --- impact and plan in China Dr. Zhao Yanlin Chinese Center for Disease Control & Prevention Dr. Richard O Brien FIND April. 16, 2013 Progress Contribution for

More information

Supplementary appendix

Supplementary appendix Supplementary appendix This appendix formed part of the original submission and has been peer reviewed. We post it as supplied by the authors. Supplement to: Churchyard GJ, Stevens WS, Mametja LD, et al.

More information

How best to structure a laboratory network with new technologies

How best to structure a laboratory network with new technologies How best to structure a laboratory network with new technologies Cristina Gutierrez, MD, PhD Uniting to scale up TB care in Central Asia 14 and 15 April 2011 Tashkent, Uzbekistan New laboratory diagnostics

More information

New Standards for an Old Disease:

New Standards for an Old Disease: New Standards for an Old Disease: Practical Implications of the TB Standards TB Prevention and Control Saskatchewan September 16, 2015 Practical Implications of the TB Standards Learning Objectives At

More information

Subgroup Report Prevalence Survey. Ikushi Onozaki WHO/HQ/HTM/STB/TBS

Subgroup Report Prevalence Survey. Ikushi Onozaki WHO/HQ/HTM/STB/TBS Subgroup Report Prevalence Survey Ikushi Onozaki WHO/HQ/HTM/STB/TBS Role of sub-group Facilitate planning, implementation and reporting of National TB surveys in the 21 priority countries designated by

More information

TB Prevalence Survey. -Census, Interview and X ray- Ikushi Onozaki MD, MPH STB, WHO Geneva

TB Prevalence Survey. -Census, Interview and X ray- Ikushi Onozaki MD, MPH STB, WHO Geneva TB Prevalence Survey -Census, Interview and X ray- Ikushi Onozaki MD, MPH STB, WHO Geneva Census: Population & Eligibility UN estimate vs. Local estimate: Issue in CDR and burden estimate (Total: 14 mil

More information

Ram Sharan Gopali (MPH) Executive Director

Ram Sharan Gopali (MPH) Executive Director Ram Sharan Gopali (MPH) Executive Director Basic Facts of Nepal Nepal is a landlocked country located in the WHO Asian region at the edge of the Himalaya between India and the Peoples Republic of China

More information

Ministry of Health. National Tuberculosis Control Program INTEGRATED TB HIV PROGRAM REPORT (JANUARY JUNE 2015)

Ministry of Health. National Tuberculosis Control Program INTEGRATED TB HIV PROGRAM REPORT (JANUARY JUNE 2015) Ministry of Health National Tuberculosis Control Program INTEGRATED TB HIV PROGRAM REPORT (JANUARY JUNE 2015) Contents Executive summary... 2 Background... 3 National Tuberculosis Program Overview... 3

More information

Principle of Tuberculosis Control. CHIANG Chen-Yuan MD, MPH, DrPhilos

Principle of Tuberculosis Control. CHIANG Chen-Yuan MD, MPH, DrPhilos Principle of Tuberculosis Control CHIANG Chen-Yuan MD, MPH, DrPhilos Estimated global tuberculosis burden 2015 an estimated 10.4 million incident cases of TB (range, 8.7 million 12.2 million) 142 cases

More information

COMMUNITY-BASED TBHIV CASE-FINDING KENYAN EXPERIENCE

COMMUNITY-BASED TBHIV CASE-FINDING KENYAN EXPERIENCE COMMUNITY-BASED TBHIV CASE-FINDING KENYAN EXPERIENCE Exposing a hidden epidemic Kenya TB/HIV TEAM Introduction Population: 40 million 15 th among the 22 high TB burden countries 2012: TB case notification

More information

Analysis of TB prevalence surveys

Analysis of TB prevalence surveys Workshop and training course on TB prevalence surveys with a focus on field operations Analysis of TB prevalence surveys Day 8 Thursday, 4 August 2011 Phnom Penh Babis Sismanidis with acknowledgements

More information

Evaluation of Genxpert Real Time PCR POC in the Diagnosis of Multidrug Resistant TB Among Patients Attending NTBLTC Saye-Zaria Nigeria

Evaluation of Genxpert Real Time PCR POC in the Diagnosis of Multidrug Resistant TB Among Patients Attending NTBLTC Saye-Zaria Nigeria RESEARCH ARTICLE Open Access Journal of Infectious Diseases and Pathogenesis ISSN 577-7939 Evaluation of Genxpert Real Time PCR POC in the Diagnosis of Multidrug Resistant TB Among Patients Attending NTBLTC

More information

Definitions and reporting framework for tuberculosis 2013 revision. Dennis Falzon Global Forum of Xpert MTB/RIF Implementers Annecy 17 April 2013

Definitions and reporting framework for tuberculosis 2013 revision. Dennis Falzon Global Forum of Xpert MTB/RIF Implementers Annecy 17 April 2013 Definitions and reporting framework for tuberculosis 2013 revision Dennis Falzon Global Forum of Xpert MTB/RIF Implementers Annecy 17 April 2013 2-year revision process WHO/HTM/TB/2013.2 2 www.who.int/iris/bitstream/10665/79199/1/9789241505345_eng.pdf

More information

National TB prevalence surveys

National TB prevalence surveys National TB prevalence surveys 2009-2015 小野崎郁史 Ikushi Onozaki Irwin Law TB Monitoring & Evaluation Global TB Programme WHO Mandate WHO Global Task Force on TB Impact Measurement To produce a robust, rigorous

More information

National tuberculosis prevalence surveys in Asia, : an overview of results and lessons learned

National tuberculosis prevalence surveys in Asia, : an overview of results and lessons learned Tropical Medicine and International Health doi:10.1111/tmi.12534 volume 20 no 9 pp 1128 1145 september 2015 National tuberculosis prevalence surveys in Asia, 1990 2012: an overview of results and lessons

More information

World Journal of Pharmaceutical and Life Sciences WJPLS

World Journal of Pharmaceutical and Life Sciences WJPLS wjpls, 2019, Vol. 5, Issue 2, 01-06 Research Article ISSN 2454-2229 WJPLS www.wjpls.org SJIF Impact Factor: 5.008 COMPARATIVE STUDY BETWEEN GENEXPERT MTB/RIF ASSAY AND DIRECT SMEAR MICROSCOPY(DSM) FOR

More information

Systematic screening for active TB operational manual and tool to help prioritization

Systematic screening for active TB operational manual and tool to help prioritization Systematic screening for active TB operational manual and tool to help prioritization Wolfheze 2015 Knut Lönnroth, Global TB Programme, 1 Strong recommendations = Should be screened in all settings 1.

More information

HIV Clinicians Society Conference TB/HIV Treatment Cascade

HIV Clinicians Society Conference TB/HIV Treatment Cascade HIV Clinicians Society Conference-2012 TB/HIV Treatment Cascade Dr Judith Mwansa-Kambafwile Wits Reproductive Health & HIV Institute University of Witwatersrand TB/HIV Treatment Cascade Overview TB stats

More information

The Republic of Uganda. The Uganda National Tuberculosis Prevalence Survey, Survey Report

The Republic of Uganda. The Uganda National Tuberculosis Prevalence Survey, Survey Report The Republic of Uganda The Uganda National Tuberculosis Prevalence Survey, 2014-2015 Survey Report 1 Acknowledgements Many people and institutions have contributed to the conceptualization, proposal development,

More information

TB FIT Modelling. 24th Annual PhilCAT Convention. Ivor Langley and Ewan Tomeny Liverpool School of Tropical Medicine AUGUST 2017

TB FIT Modelling. 24th Annual PhilCAT Convention. Ivor Langley and Ewan Tomeny Liverpool School of Tropical Medicine AUGUST 2017 TB FIT Modelling 24th Annual PhilCAT Convention Ivor Langley and Ewan Tomeny Liverpool School of Tropical Medicine AUGUST 2017 TB-FIT - Objectives 1. Develop a computer model of patient pathways for diagnosis

More information

Report of WS on Prevalence Survey in Beijing. Norio Yamada RIT/JATA

Report of WS on Prevalence Survey in Beijing. Norio Yamada RIT/JATA Report of WS on Prevalence Survey in Beijing Norio Yamada RIT/JATA Objectives of WS To review prevalence survey recently conducted and currently planed To review and discuss TB screening methods in prevalence

More information

Diagnosing Xpert MTB/RIF negative TB suspects: Impact and cost of an alternative algorithm

Diagnosing Xpert MTB/RIF negative TB suspects: Impact and cost of an alternative algorithm Diagnosing Xpert MTB/RIF negative TB suspects: Impact and cost of an alternative algorithm Kathryn Schnippel 1, Gesine Meyer-Rath 1,2, Lawrence Long 1, Wendy Stevens 3,4, Ian Sanne 1,2, and Sydney Rosen

More information

UGANDA NATIONAL TUBERCULOSIS AND LEPROSY CONTROL PROGRAMME

UGANDA NATIONAL TUBERCULOSIS AND LEPROSY CONTROL PROGRAMME MINISTRY OF HEALTH UGANDA TIOL TUBERCULOSIS AND LEPROSY CONTROL PROGRAMME Revised Strategic Plan 2015/16-2019/20 Monitoring and Evaluation Plan Narrative of the Operational, Budget and Technical Assistance

More information

Recognizing MDR-TB in Children. Ma. Cecilia G. Ama, MD 23 rd PIDSP Annual Convention February 2016

Recognizing MDR-TB in Children. Ma. Cecilia G. Ama, MD 23 rd PIDSP Annual Convention February 2016 Recognizing MDR-TB in Children Ma. Cecilia G. Ama, MD 23 rd PIDSP Annual Convention 17-18 February 2016 Objectives Review the definitions and categorization of drugresistant tuberculosis Understand the

More information

APHL Global Health TB-related Activities

APHL Global Health TB-related Activities APHL Global Health TB-related Activities 5th National TB Conference 11-13 August 2008 San Diego, CA Travis Jobe APHL Global Health Projects Haiti Strategic planning TA & training Barbados WHO Twinning

More information

Application of the Onion model to assess the extent of missing tuberculosis cases by the National Programmes

Application of the Onion model to assess the extent of missing tuberculosis cases by the National Programmes Application of the Onion model to assess the extent of missing tuberculosis cases by the National Programmes Dr Amal Bassili Stop TB unit, WHO, Regional Office for the Eastern Mediterranean Surveillance

More information

Kenya Perspectives. Post-2015 Development Agenda. Tuberculosis

Kenya Perspectives. Post-2015 Development Agenda. Tuberculosis Kenya Perspectives Post-2015 Development Agenda Tuberculosis SPEAKERS Anna Vassall Anna Vassall is Senior Lecturer in Health Economics at the London School of Hygiene and Tropical Medicine. She is a health

More information

Guidance on Matching Funds: Tuberculosis Finding the Missing People with TB

Guidance on Matching Funds: Tuberculosis Finding the Missing People with TB February 2017 Guidance on Matching Funds: Tuberculosis Finding the Missing People with TB 1. Background TB is the leading cause of death by infectious disease, killing 1.8 million people in 2015. Each

More information

Experiences in scaling up childhood TB activities- Pakistan

Experiences in scaling up childhood TB activities- Pakistan Experiences in scaling up childhood TB activities- Pakistan Farhana Amanullah Childhood TB subgroup meeting 29 th October, 2013- Paris, France Childhood TB in Pakistan TB Prevalence rate is estimated at

More information

Laboratory Diagnostic Techniques. Hugo Donaldson Consultant Microbiologist Imperial College Healthcare NHS Trust

Laboratory Diagnostic Techniques. Hugo Donaldson Consultant Microbiologist Imperial College Healthcare NHS Trust Laboratory Diagnostic Techniques Hugo Donaldson Consultant Microbiologist Imperial College Healthcare NHS Trust Learning Objectives 1) When to consider a diagnosis of TB 2) When to consider a referral

More information

Paediatric TB: disease burden estimation and the opportunities it creates to strengthening surveillance

Paediatric TB: disease burden estimation and the opportunities it creates to strengthening surveillance Paediatric TB: disease burden estimation and the opportunities it creates to strengthening surveillance Workshop 04 44 th Union World Conference on Lung Health Paris, 31 October, 2013 GLOBAL TB PROGRAMME

More information

Diagnosis of tuberculosis in children

Diagnosis of tuberculosis in children Diagnosis of tuberculosis in children H Simon Schaaf Desmond Tutu TB Centre Department of Paediatrics and Child Health, Stellenbosch University, and Tygerberg Children s Hospital (TCH) Estimated TB incidence

More information

Latent Tuberculosis Infections Controversies in Diagnosis and Management Update 2016

Latent Tuberculosis Infections Controversies in Diagnosis and Management Update 2016 Latent Tuberculosis Infections Controversies in Diagnosis and Management Update 2016 Randy Culpepper, MD, MPH Deputy Heath Officer/Medical Director Frederick County Health Department March 16, 2016 2 No

More information

Prevalence of tuberculosis (TB) infection and disease among adolescents western Kenya: preparation for future TB vaccine trials

Prevalence of tuberculosis (TB) infection and disease among adolescents western Kenya: preparation for future TB vaccine trials Prevalence of tuberculosis (TB) infection and disease among adolescents western Kenya: preparation for future TB vaccine trials Videlis Nduba 1,2, Peter Onyango 1, Anja Van t Hoog 1,3, Anthony Hawkridge

More information

TB In Detroit 2011* Early TB: Smudge Sign. Who is at risk for exposure to or infection with TB? Who is at risk for TB after exposure or infection?

TB In Detroit 2011* Early TB: Smudge Sign. Who is at risk for exposure to or infection with TB? Who is at risk for TB after exposure or infection? Those oral antibiotics are just not working! Inpatient Standards of Care & Discharge Planning S/He s in the Hospital: Now What Do I Do? Dana G. Kissner, MD TB Intensive Workshop, Lansing, MI 2012 Objectives:

More information

Theory-guided mixed methods approach in improving case detection of tuberculosis in children. Jacquie Oliwa

Theory-guided mixed methods approach in improving case detection of tuberculosis in children. Jacquie Oliwa Theory-guided mixed methods approach in improving case detection of tuberculosis in children Jacquie Oliwa Outline Background Statement of the problem Role of theory in improvement Study aims/methods Theoretical

More information

TB IN EMERGENCIES. Disease Control in Humanitarian Emergencies (DCE)

TB IN EMERGENCIES. Disease Control in Humanitarian Emergencies (DCE) TB IN EMERGENCIES Department of Epidemic and Pandemic Alert and Response (EPR) Health Security and Environment Cluster (HSE) (Acknowledgements WHO Stop TB Programme WHO/STB) 1 Why TB? >33% of the global

More information

Xpert MTB/RIF Ultra: Understanding this new diagnostic and who will have access to it

Xpert MTB/RIF Ultra: Understanding this new diagnostic and who will have access to it Xpert MTB/RIF Ultra: Understanding this new diagnostic and who will have access to it Angela Starks, PhD Chief, Laboratory Branch Division of TB Elimination Matt Bankowski, PhD, MS, D(ABMM), HCLD/CC(ABB)

More information

INTENSIFIED TB CASE FINDING

INTENSIFIED TB CASE FINDING INTENSIFIED TB CASE FINDING My friends call me Intensified Case Finding (ICF) I undertake regularly screening all people with, or at high risk of HIV, for symptoms of TB in health care facilities, communities

More information

Research Methods for TB Diagnostics. Kathy DeRiemer, PhD, MPH University of California, Davis Shanghai, China: May 8, 2012

Research Methods for TB Diagnostics. Kathy DeRiemer, PhD, MPH University of California, Davis Shanghai, China: May 8, 2012 Research Methods for TB Diagnostics Kathy DeRiemer, PhD, MPH University of California, Davis Shanghai, China: May 8, 2012 Overview Why do we need good TB diagnostics? What works? What doesn t work? How

More information

Implementation and scale-up of the Xpert MTB/RIF system for rapid diagnosis of TB and MDR-TB. Global Consultation

Implementation and scale-up of the Xpert MTB/RIF system for rapid diagnosis of TB and MDR-TB. Global Consultation Implementation and scale-up of the Xpert MTB/RIF system for rapid diagnosis of TB and MDR-TB Global Consultation Geneva, 30 November 2010 Mario C. Raviglione, M.D. Director, Stop TB Department WHO, Geneva,

More information

Mycobacteria & Tuberculosis PROF.HANAN HABIB & PROF ALI SOMILY DEPRTMENT OF PATHOLOGY, MICROBIOLOGY UNIT COLLEGE OF MEDICINE

Mycobacteria & Tuberculosis PROF.HANAN HABIB & PROF ALI SOMILY DEPRTMENT OF PATHOLOGY, MICROBIOLOGY UNIT COLLEGE OF MEDICINE Mycobacteria & Tuberculosis PROF.HANAN HABIB & PROF ALI SOMILY DEPRTMENT OF PATHOLOGY, MICROBIOLOGY UNIT COLLEGE OF MEDICINE Objectives l Recognize that tuberculosis as a chronic disease mainly affecting

More information

Same-day diagnosis of tuberculosis by microscopy. Policy statement

Same-day diagnosis of tuberculosis by microscopy. Policy statement Same-day diagnosis of tuberculosis by microscopy Policy statement March 2010 Contents Abbreviations Executive summary 1. Background 2. Evidence for policy formulation 2.1 Synthesis of evidence 2.2 Management

More information

Tuberculosis case detection in Nigeria, the unfinished agenda

Tuberculosis case detection in Nigeria, the unfinished agenda Tropical Medicine and International Health doi:10.1111/tmi.12558 volume 20 no 10 pp 1396 1402 october 2015 Tuberculosis case detection in Nigeria, the unfinished agenda Joshua Obasanya 1, Saddiq T. Abdurrahman

More information

10/3/2017. Updates in Tuberculosis. Global Tuberculosis, WHO 2015 report. Objectives. Disclosures. I have nothing to disclose

10/3/2017. Updates in Tuberculosis. Global Tuberculosis, WHO 2015 report. Objectives. Disclosures. I have nothing to disclose Disclosures Updates in Tuberculosis I have nothing to disclose Chris Keh, MD Assistant Clinical Professor, Division of Infectious Diseases, UCSF TB Controller, TB Prevention and Control Program, Population

More information

Report on WHO Policy Statements

Report on WHO Policy Statements Report on WHO Policy Statements Christopher Gilpin TB Diagnostics and Laboratory Strengthening Unit Secretariat, Global Laboratory Initiative Stop TB Department, WHO Geneva New Diagnostics Working Group

More information

Implementing revised TB/HIV recording and reporting tools Country Experience. Dr Nathan Kapata National TB/ Leprosy Programme Manager

Implementing revised TB/HIV recording and reporting tools Country Experience. Dr Nathan Kapata National TB/ Leprosy Programme Manager Implementing revised TB/HIV recording and reporting tools Country Experience Dr Nathan Kapata National TB/ Leprosy Programme Manager Outline Objective Background Implementation of TB/HIV collaborative

More information

TB Program Management San Antonio, Texas November 5-7, 2008

TB Program Management San Antonio, Texas November 5-7, 2008 TB Program Management San Antonio, Texas November 5-7, 2008 Infection Control Lynelle Phillips, RN, MPH November 7, 2008 Infection Control Lynelle Phillips, RN MPH Nurse Consultant Heartland National TB

More information

Algorithmic Approaches to Child TB Management in Resource-limited Settings

Algorithmic Approaches to Child TB Management in Resource-limited Settings Algorithmic Approaches to Child TB Management in Resource-limited Settings Steve Graham Centre for International Child Health University of Melbourne Department of Paediatrics Royal Children s Hospital

More information

Tuberculosis Populations at Risk

Tuberculosis Populations at Risk Tuberculosis Populations at Risk One-third of the world is infected with TB, an average of one new infection per second Two million people died from tuberculosis in 2010, 1 every 20 seconds TB is the leading

More information

Health Care Worker Training on Roll Out New TB Diagnostic Test. Prepared by: City Health (J Caldwell) & NHLS (M Bosman & I Noordien)

Health Care Worker Training on Roll Out New TB Diagnostic Test. Prepared by: City Health (J Caldwell) & NHLS (M Bosman & I Noordien) Health Care Worker Training on Roll Out New TB Diagnostic Test Prepared by: City Health (J Caldwell) & NHLS (M Bosman & I Noordien) Overview Specimen Collection Investigations to request Sorting & registering

More information

The need for new TB diagnostics in children and the way forward

The need for new TB diagnostics in children and the way forward The need for new TB diagnostics in children and the way forward Steve Graham Centre for International Child Health University of Melbourne Department of Paediatrics Royal Children s Hospital Melbourne

More information

Intensive Case Finding of TB in Children Using the MCH approach

Intensive Case Finding of TB in Children Using the MCH approach Intensive Case Finding of TB in Children Using the MCH approach Senait Kebede, MD (Ped), MPH Hon. Associate Professor of Pediatrics,SPHMMC Adjunct Faculty, Global Health, Emory University Director, International

More information

Response to Treatment in Sputum Smear Positive Pulmonary Tuberculosis Patients In relation to Human Immunodeficiency Virus in Kano, Nigeria.

Response to Treatment in Sputum Smear Positive Pulmonary Tuberculosis Patients In relation to Human Immunodeficiency Virus in Kano, Nigeria. Response to Treatment in Sputum Smear Positive Pulmonary Tuberculosis Patients In relation to Human Immunodeficiency Virus in Kano, Nigeria. Yusuf Mohammed, Mukhtar Dauda, Ifeanyi Oyeyi TB/HIV Unit, International

More information

Ethiopia. Targeted Tuberculosis Case Finding Interventions in Six Mining Shafts in Remote Districts of Oromia Region in Ethiopia PROJECT CONTEXT

Ethiopia. Targeted Tuberculosis Case Finding Interventions in Six Mining Shafts in Remote Districts of Oromia Region in Ethiopia PROJECT CONTEXT Technical BRIEF Photo Credit: Challenge TB Targeted Tuberculosis Case Finding Interventions in Six Mining Shafts in Remote Districts of Oromia Region in Ethiopia PROJECT CONTEXT Ethiopia is the second-most

More information

CDPH - CTCA Joint Guidelines Guideline for Micobacteriology Services In California

CDPH - CTCA Joint Guidelines Guideline for Micobacteriology Services In California CDPH - CTCA Joint Guidelines Guideline for Micobacteriology Services In California These guidelines are intended to be used as an educational aid to help clinicians make informed decisions about patient

More information

Nguyen Van Hung (NTP, Viet Nam)

Nguyen Van Hung (NTP, Viet Nam) Technical Consultation Meeting on the Programmatic Management of Latent Tuberculosis Infection 31 August-1 September 2017, Seoul, Republic Korea Adopting new LTBI diagnostics at country level: perspective

More information

Predictive statistical modelling approach to estimating TB burden. Sandra Alba, Ente Rood, Masja Straetemans and Mirjam Bakker

Predictive statistical modelling approach to estimating TB burden. Sandra Alba, Ente Rood, Masja Straetemans and Mirjam Bakker Predictive statistical modelling approach to estimating TB burden Sandra Alba, Ente Rood, Masja Straetemans and Mirjam Bakker Overall aim, interim results Overall aim of predictive models: 1. To enable

More information

Qian Gao Fudan University

Qian Gao Fudan University Qian Gao Fudan University Outline Background & Objectives Genotyping methods Establish the epidemiological field sites Preliminary results of Molecular epidemiology of TB in China Molecular epidemiology

More information

Ken Jost, BA, has the following disclosures to make:

Ken Jost, BA, has the following disclosures to make: Diagnosis of TB Disease: Laboratory Ken Jost, BA May 10, 2017 TB Intensive May 9-12, 2017 San Antonio, TX EXCELLENCE EXPERTISE INNOVATION Ken Jost, BA, has the following disclosures to make: No conflict

More information

Utilizing All the Tools in the TB Toolbox

Utilizing All the Tools in the TB Toolbox Utilizing All the Tools in the TB Toolbox Sandra Morano, B.A., R.N. Public Health Nurse, City of Stamford, CT TB Talk The New England TB Consortium March 18, 2010 Background TB Program, City of Stamford,

More information

11/3/2009 SECOND EDITION Madhukar Pai McGill University. ISTC Training Modules Introduction

11/3/2009 SECOND EDITION Madhukar Pai McGill University. ISTC Training Modules Introduction SECOND EDITION 2009 Madhukar Pai McGill University Introduction 1 Purpose of ISTC ISTC Version 2: Key Points 21 Standards Differ from existing guidelines: standards present what should be done, whereas,

More information

Supplementary Appendix

Supplementary Appendix Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Cain KP, McCarthy KD, Heilig CM, et al. An algorithm for tuberculosis

More information

Revitalising community engagement for TB and TB/HIV prevention, diagnosis and treatment

Revitalising community engagement for TB and TB/HIV prevention, diagnosis and treatment 17 th TB/HIV Core Group meeting, Beijing, China. November 11, 2011 Revitalising community engagement for TB and TB/HIV prevention, diagnosis and treatment Haileyesus Getahun Stop TB Department WHO Outline

More information

Akujobi CN, Okoro CE, Anyabolu AE, Okonkwo RC, Onwunzo MC and Chukwuka CP

Akujobi CN, Okoro CE, Anyabolu AE, Okonkwo RC, Onwunzo MC and Chukwuka CP Akujobi CN, Okoro CE, Anyabolu AE, Okonkwo RC, Onwunzo MC and Chukwuka CP Tuberculosis (TB) is the most common opportunistic infection in Human Immunodeficiency Virus (HIV)-infected patients. 1 HIV-infected

More information

Progress with intensified TB Case Finding in Nigeria. Dr. E.B.A. Coker MD, MPH Coordinator National HIV/AIDS Programme

Progress with intensified TB Case Finding in Nigeria. Dr. E.B.A. Coker MD, MPH Coordinator National HIV/AIDS Programme Progress with intensified TB Case Finding in Nigeria Dr. E.B.A. Coker MD, MPH Coordinator National HIV/AIDS Programme Presentation outline. Country information. HIV/AIDS profile. TB burden. Progress with

More information

Experience with implementation of Xpert MTB/RIF in India. Dr K S Sachdeva Addl. DDG (TB), Government of India

Experience with implementation of Xpert MTB/RIF in India. Dr K S Sachdeva Addl. DDG (TB), Government of India Experience with implementation of Xpert MTB/RIF in India Dr K S Sachdeva Addl. DDG (TB), Government of India Background Two ongoing projects being implemented in India, under RNTCP by FIND Gene Xpert feasibility

More information

Soedarsono Department of Pulmonology & Respiratory Medicine Faculty of Medicine, Universitas Airlangga Dr. Soetomo General Hospital

Soedarsono Department of Pulmonology & Respiratory Medicine Faculty of Medicine, Universitas Airlangga Dr. Soetomo General Hospital Soedarsono Department of Pulmonology & Respiratory Medicine Faculty of Medicine, Universitas Airlangga Dr. Soetomo General Hospital There were an estimated 10.4 million new TB cases in 2015, higher than

More information

Comparative evaluation of diagnostic performance of Xpert between paired IS and GW in children <3.5 years in Cape Town, SA

Comparative evaluation of diagnostic performance of Xpert between paired IS and GW in children <3.5 years in Cape Town, SA Comparative evaluation of diagnostic performance of Xpert between paired IS and GW in children

More information

National Xpert MTB/RIF Programme

National Xpert MTB/RIF Programme National Xpert MTB/RIF Programme 1. Background to Project This project was initiated at the request of the Honorable Minister of Health, Dr Aaron Motsoaledi, in early 2011, following the World Health Organization

More information

Effect of anti-stigma legislation on the level of stigma directed towards persons living with HIV in Nigeria

Effect of anti-stigma legislation on the level of stigma directed towards persons living with HIV in Nigeria Effect of anti-stigma legislation on the level of stigma directed towards persons living with HIV in Nigeria Oluwole FAJEMISIN 22 nd July 2014 23/07/2014 1 Agenda Background Methodology Results Conclusions

More information

TB prevention studies in PLHIV: recent updates and what can they tell us for the future?

TB prevention studies in PLHIV: recent updates and what can they tell us for the future? TB prevention studies in PLHIV: recent updates and what can they tell us for the future? Richard E. Chaisson, MD Center for AIDS Research Center for TB Research Johns Hopkins University TB/HIV Working

More information

Xpert MTB/RIF test Rollout and Implementation Plan

Xpert MTB/RIF test Rollout and Implementation Plan Xpert MTB/RIF test Rollout and Implementation Plan UNITED REPUBLIC OF TANZANIA MINISTRY OF HEALTH AND SOCIAL WELFARE NATIONAL TUBERCULOSIS AND LEPROSY PROGRAMME 6 Samora Machel Avenue P.O. Box 9083 11478

More information

TB Contact Investigation

TB Contact Investigation Ann Raftery, RN, PHN, MS Curry International TB Center Overview Contact investigation as a core TB control and elimination activity Components of TB Contact Investigation TB Control Priority Strategies.

More information

TB Intensive San Antonio, Texas November 11 14, 2014

TB Intensive San Antonio, Texas November 11 14, 2014 TB Intensive San Antonio, Texas November 11 14, 2014 Diagnosis of TB: Laboratory Ken Jost, BA November 12, 2014 Ken Jost, BA has the following disclosures to make: No conflict of interests No relevant

More information

Dr Francis Ogaro MTRH ELDORET

Dr Francis Ogaro MTRH ELDORET Dr Francis Ogaro MTRH ELDORET TB in children often severe, disseminated and can progress rapidly and with poor outcome TB diagnosis in children has relied on clinical, imaging, microscopy and TST findings.

More information

The Epidemiology of Tuberculosis in Minnesota,

The Epidemiology of Tuberculosis in Minnesota, The Epidemiology of Tuberculosis in Minnesota, 2011 2015 Minnesota Department of Health Tuberculosis Prevention and Control Program (651) 201-5414 Tuberculosis surveillance data for Minnesota are available

More information

A pilot study measuring the kinetic profile of IP-10 over the first 14 days of PTB chemotherapy

A pilot study measuring the kinetic profile of IP-10 over the first 14 days of PTB chemotherapy A pilot study measuring the kinetic profile of IP-10 over the first 14 days of PTB chemotherapy Dr Rachel Saunders Dr Matthew Blakiston Liverpool School of Tropical Medicine Background TB is responsible

More information

MODULE SIX. Global TB Institutions and Policy Framework. Treatment Action Group TB/HIV Advocacy Toolkit

MODULE SIX. Global TB Institutions and Policy Framework. Treatment Action Group TB/HIV Advocacy Toolkit MODULE SIX Global TB Institutions and Policy Framework Treatment Action Group TB/HIV Advocacy Toolkit 1 Topics to be Covered Global TB policy and coordinating structures The Stop TB Strategy TB/HIV collaborative

More information

Virtual Implementation Evaluation of Tuberculosis diagnostics in Tanzania Ivor Langley, Liverpool School of Tropical Medicine

Virtual Implementation Evaluation of Tuberculosis diagnostics in Tanzania Ivor Langley, Liverpool School of Tropical Medicine Virtual Implementation Evaluation of Tuberculosis diagnostics in Tanzania Ivor Langley, Liverpool School of Tropical Medicine 3rd sector OR and developing countries 27th March 2013, London School of Economics

More information

Costing of the Sierra Leone National Strategic Plan for TB

Costing of the Sierra Leone National Strategic Plan for TB Costing of the Sierra Leone National Strategic Plan for TB 2016-2020 Introduction The Government of Sierra Leone established the National Leprosy Control Programme in 1973 with support from the German

More information

Diagnostic challenges of active childhood TB in Tanzania. Michala Vaaben Rose, MD, Ph.D Department of Infectious Diseases, Hvidovre

Diagnostic challenges of active childhood TB in Tanzania. Michala Vaaben Rose, MD, Ph.D Department of Infectious Diseases, Hvidovre Diagnostic challenges of active childhood TB in Tanzania Michala Vaaben Rose, MD, Ph.D Department of Infectious Diseases, Hvidovre 1 Diagnosis of Childhood Tuberculosis Muheza hospital, TZ Hilleroedhospital.dk

More information

Supplementary appendix

Supplementary appendix Supplementary appendix This appendix formed part of the original submission and has been peer reviewed. We post it as supplied by the authors. Supplement to: Dorman S E, Schumacher S G, Alland D, et al.

More information